Global Renal Insufficiency Market Trends 2025–2029: Regional Outlook and Sizing Analysis
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Renal Insufficiency Market Be Worth By 2029?
The market size for renal insufficiency has experienced swift expansion in the past few years. Its anticipated growth projection is from $10.87 billion in 2024 to $12.1 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.4%. The historical growth pattern can be associated with a rising count of hypertension and diabetes cases, higher occurrence of chronic kidney disease (CKD), an increase in urinary tract obstruction cases, an aging demographic, and a surge in knowledge and consciousness about kidney health.
The market size for renal insufficiency is anticipated to expand significantly in the coming years, reaching $18.52 billion in 2029 with a CAGR of 11.2%. Predicted growth during the forecast period is due to the rise in acute kidney injuries (AKI), the popularity of home-based treatment alternatives, increasing healthcare expenses, and investment in R&D. Key trends for the upcoming period encompass progress in medical technology, continuous improvements in technology and therapy approaches, incorporating personalized medicine, advancements in dialysis techniques, and the creation of novel and innovative drugs.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21271&type=smp
Which Key Factors Are Fueling Growth In The Renal Insufficiency Market?
The rise in high blood pressure and diabetes incidences are foreseen to stimulate the expansion of the renal insufficiency market in the future. Elements like unhealthy diet, physical inactivity, obesity, genetic factors, and an aging demographic result in high blood pressure and diabetes. Both conditions are known to cause significant damage to the kidneys, leading to renal insufficiency. High blood pressure scars and reduces kidney blood vessel filtration, and high blood sugar due to diabetes thickens and overworks kidney vessels, consequently speeding the process of kidney damage. For example, the National Health Service, a governmental agency in the UK, revealed in May 2024 that the South East saw a surge in high blood pressure diagnoses by 71,120 patients – a 5.4% increase – in December 2023 compared to the same month the previous year. Also, the British Diabetic Association, a charity in the UK, reported in April 2023 that 4.3 million people in the UK are diagnosed with diabetes. With these rising numbers, the growth of the renal insufficiency market is fuelled by the escalating instances of high blood pressure and diabetes.
Which Segmentation Factors Are Critical In The Renal Insufficiency Market Analysis?
The renal insufficiencymarket covered in this report is segmented –
1) By Treatment Type: Medications; Dialysis; Kidney Transplantation; Other Treatment Types
2) By Disease Stage: Chronic Kidney Disease (CKD) Stages; End-Stage Renal Disease (ESRD)
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By End-User: Dialysis Centers; Hospital And Clinics; Research And Academic Institutes
Subsegments:
1) By Medications: Angiotensin-Converting Enzyme (ACE) Inhibitors; Angiotensin II Receptor Blockers (ARBs); Diuretics; Erythropoiesis-Stimulating Agents (ESAs); Phosphate Binders; Sodium Bicarbonate
2) By Dialysis: Hemodialysis; Peritoneal Dialysis; Home Dialysis; Continuous Renal Replacement Therapy (CRRT)
3) By Kidney Transplantation: Living Donor Kidney Transplant; Deceased Donor Kidney Transplant; Kidney Transplant Immunosuppressive Therapy
4) By Other Treatment Types: Lifestyle And Dietary Modifications; Stem Cell Therapy; Gene Therapy
What New Opportunities Are Emerging From Trends In The Renal Insufficiency Market?
Major companies in the renal insufficiency market are focusing on the development of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to manage renal and cardiovascular complications in patients suffering from diabetes and chronic kidney disease (CKD). GLP-1 RAs help improve glucose regulation, decrease inflammation, and reduce oxidative stress in the kidneys, thereby slowing renal insufficiency progression. For example, in January 2025, Novo Nordisk, a pharmaceutical firm based in Denmark, received approval from the Food and Drug Administration (FDA) for Ozempic (semaglutide) to lower the risk of kidney disease progression, kidney failure, and cardiovascular death in adults with type 2 diabetes and CKD. This approval underscores the increasing focus on GLP-1 RAs as a dual therapeutic strategy for managing both diabetes and renal insufficiency, addressing significant unmet needs in patients with advancing CKD.
Which Players Are Shaping The Competitive Landscape Of The Renal Insufficiency Market?
Major companies operating in the renal insufficiency market are Kaiser Permanente, Johnson & Johnson, Roche Holding AG, Sanofi S.A., Abbott Laboratories, Medtronic plc, Amgen Inc., Asahi Kasei Medical Co. Ltd., Fujifilm Holdings Corporation, Fresenius Medical Care, Toray Industries Inc., Baxter International Inc., Boehringer Ingelheim, DaVita Inc., Eisai Co. Ltd., Nipro Corporation, Biocon Limited, HemoCue AB, Rockwell Medical, Mitsubishi Tanabe Pharma Corporation, Sorin Group.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/renal-insufficiency-global-market-report
Which Region Is Likely To Register The Fastest Growth In The Renal Insufficiency Market?
North America was the largest region in the renal insufficiency market in 2024. The regions covered in the renal insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21271&type=smp
Browse Through More Reports Similar to the Global Renal Insufficiency Market 2025, By The Business Research Company
End Stage Renal Disease Esrd Drug Global Market Report 2025
Hepatorenal Syndrome Treatment Global Market Report 2025
Renal Denervation Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/renal-denervation-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
